Patheon Places Big Bet with Mova Acquisition

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-01-02-2005
Volume 29
Issue 1

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
CPHI Milan 2024: Highlighting the Benefits of Integrated Services